Eighty-three patients evaluated for thoracic aortic disease with a 256-MDCT scanner were imaged at 120 kV ( group 1 ) or 100 kV ( group 2 ) with the same contrast protocol ( 90 mL iopromide 370 mg I/mL at 3.5 mL/s ) .